Pharmaceuticals · NDA Manufacturing Support
Manufacturing and Validation Support for an NDA
The short answer
This is the site-side companion to an NDA filing: making sure the validated process, the control strategy and the records at the manufacturing site match what the application says, and that the people there can explain it during a pre-approval inspection.
Why this matters
- Pre-approval inspections test whether the filing describes reality.
- A defensible validation package is built during execution, not written afterward.
- Subject matter experts who cannot explain their own rationale create findings out of good science.
Applicable regulations and standards
- 21 CFR Part 211
- cGMP for finished pharmaceuticals.
- FDA Process Validation Guidance (2011)
- Lifecycle validation expectations.
- FDA Compliance Program 7346.832
- Pre-approval inspection program objectives.
What our consultants actually do
- Review the validation package for technical defensibility before filing
- Implement the filed control strategy in site procedures and batch records
- Assess analytical method validation and transfer at the release laboratory
- Conduct readiness assessments and coach subject matter experts
- Remediate gaps between filed commitments and site practice
Across the product lifecycle
01 / DEVELOP
Data organized to justify filed ranges.
02 / SCALE
Commercial equipment differences resolved.
03 / TRANSFER
Process and methods transferred and documented.
04 / VALIDATE
PPQ executed and reported defensibly.
05 / MANUFACTURE
Routine production under the filed control strategy.
06 / MAINTAIN
CPV trending and change-driven revalidation.
Problems we are usually called about
- Batch records that omit parameters listed as critical in the filing
- Validation reports that assert success without addressing observed variability
- Subject matter experts unfamiliar with the content of their own application
Typical deliverables
- Validation package technical review
- Control strategy implementation gap assessment
- Method validation and transfer review
- Readiness report and SME coaching plan
Frequently asked
- How long before the inspection should readiness work start?
- Far enough ahead that findings can be corrected rather than explained — typically several months, because remediating a validation gap takes longer than writing a narrative about it.
References
More for pharmaceuticals
cGMP, validation and manufacturing quality support for drug products.
- Process ValidationProcess validation for a drug product is a three-stage lifecycle: design the process and its control strategy, qualify commercial-scale performance, and then verify that the process stays in control for as long as it is used.
- Cleaning ValidationCleaning validation demonstrates that a documented cleaning procedure consistently reduces residues to scientifically justified limits on shared equipment.
- cGMP ConsultingcGMP consulting for a drug manufacturer means making 21 CFR Parts 210 and 211 operable in your facility — with procedures your staff can follow, records that reconstruct what happened and a quality unit with the authority to act.
- Technology TransferTechnology transfer succeeds or fails on what the receiving site is given: process understanding, not just a batch record.
- Quality SystemsA pharmaceutical quality system is the set of connected processes — documents, changes, deviations, CAPA, training, release, review — that keep product decisions defensible.
- IND CMC SupportSponsors filing an IND usually need two things at once: CMC content for the application and a quality system capable of overseeing clinical manufacturing.
Start a project
Tell us what you're working on.
Describe the product, the process or the problem. We will tell you honestly whether we are the right people to help, and who should be on the team if we are.